Software maker Oracle is set to gain unconditional EU antitrust clearance for its $28.3 billion acquisition of US healthcare IT company Cerne, reported Reuters.
Oracle announced the deal, its biggest ever, in December last year. It will give it access to a trove of data and could attract more healthcare clients to its cloud platform.
Cerner, a hospital facility management software-maker, produces high-end health information technology services, devices, and hardware that rely on complex troves of patient data to help navigate various aspects of the US healthcare system, including availability and coverage of medical professionals to help people get the best coverage available.
Cerner’s data can help Oracle train and improve the software maker’s artificial intelligence-based cloud services. The company, whose software traditionally ran in its customers’ data centers, has started shifting its service to cloud computing providers.
Tech giants such as Microsoft have ramped up investments in the healthcare sector, spurred by demand for cloud-based solutions during the pandemic.
RELATED: Antitrust Chronicle – Healthcare Mergers: A Post-Mortem
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.